TrialClinical cancer research : an official journal of the American Association for Cancer Research2021

Baseline Circulating Tumor Cell Count as a Prognostic Marker of PSA Response and Disease Progression in Metastatic Castrate-Sensitive Prostate Cancer (SWOG S1216).

Amir Goldkorn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.